Amgen 10K 2013 Annual report | AMGN Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: abetted, abetting, ACA, accomplishment, acquiree, agenda, aided, aiding, Arena, ASPIRE, assumption, ATL, automated, BBB, Biogen, Bioterror, bortezomib, breakaway, Calcitonin, capability, capable, carfilzomib, Chancery, Chow, CLARION, Clifford, constituent, consummated, deployment, dexamethasone, diagnosed, differentiated, distinct, dramatically, DRR, durable, dyslipidemia, en, ENDEAVOR, escalation, evolocumab, facilitate, faith, Fenner, Fitzpatric, franchise, Francisco, fungible, garland, geography, Granix, grantee, greg, grown, Herceptin, Honorable, HSBC, Hubert, IIIB, IIIC, implicate, instability, internationally, intravascular, Investor, iodine, IRA, ivabradine, John, Laura, Laurine, Lawrence, lenalidomide, lengthen, liaison, lipegfilgrastim, lipid, loan, Lonquex, loyalty, Magowan, malware, Marie, Martin, Mateo, Mead, melphalan, mg, migraine, Monsanto, Municipal, Nexavar, NutraSweet, Nutrition, OIG, Onyx, oprozomib, OS, overarching, overruling, palbociclib, partnership, Perrin, PFS, pharmacology, Phil, Pierce, Placement, play, Police, posture, pre, prednisone, preliminarily, Procoralan, proteasome, Proteolix, reconfigurable, Repo, rescission, resubmitted, Robinson, Rosen, San, science, Servier, shipment, Silverstein, simultaneously, SMBC, Smilow, Smith, SNS, Solak, sorafenib, Squibb, Stivarga, stockpile, streamlining, Stuart, subcutaneously, tangible, Tanox, threaten, trend, ultrasound, unfair, unfamiliar, unlocking, unmet, unnamed, unpaid, unravel, Velcade, velcalcetide, warehousing, Weiner, Wellcome, whichever, William, withheld, WT, zolendronic

Removed: Abbott, ablation, academic, Accountability, accretion, accuracy, admission, advice, advocacy, affinity, Affymax, alendronate, AML, AMP, analytical, androgen, anemic, ankylosing, announcement, answer, answering, antitrust, apportioned, approximating, aromatase, Arzneimittel, ASD, ASP, aspect, assembly, assure, automatically, avoid, avoidance, barrel, began, bidding, billable, binding, Biocon, Birch, blackout, block, body, borrowing, boxed, break, breakage, broad, broken, bundled, bundling, burdensome, calcimimetic, calendar, call, called, Carbonnel, catastrophic, ceiling, Celgene, Centocor, chemical, chemorefractory, children, choose, Chugai, circulation, clause, Coast, Cochrane, codon, Columbia, commensurate, compare, competent, composite, conclusion, Confirmation, congenital, consecutive, consulting, contraindicated, cooperate, core, correct, correction, count, cover, covering, created, creation, CRF, culture, Cyanamid, cyclic, cytotoxic, de, decide, deciliter, deeply, defect, deficient, define, defining, deleted, demanded, deny, denying, deprivation, dermatologic, detrimental, directed, direction, disabled, dispense, disproportionate, divide, documenting, doughnut, driver, education, eligibility, employed, enactment, encounter, encouraged, epidemiological, epidermal, essential, establishment, estate, evolve, evolved, examine, exceed, excessive, experiment, expert, explore, explored, expressing, faster, FCP, FDAAA, fermentation, fight, financed, Florida, fluoropyrimidine, FOLFIRI, FOLFOX, formulary, formulated, fostamatinib, foundation, FPL, freestanding, FSS, fusion, ganitumab, gap, GDNF, GE, generate, Georgia, Glial, glucokinase, glycol, GmbH, goal, granting, Guard, guide, HALT, Hampshire, Hawaii, Hb, healing, healthy, heard, hemoglobin, holder, hole, hormone, Hospira, hospitalization, idiopathic, immune, immunosuppressive, improved, incident, inclusion, Indian, Indiana, induction, inflation, influence, influenced, infringing, Initiative, INN, insert, insufficient, insurer, intent, intervention, invalid, investigation, involvement, irinotecan, ITP, jaw, Jersey, judicial, Junior, jury, juvenile, Kassie, KDIGO, KDOQI, KG, largely, leakage, learn, list, literature, Los, main, marrow, McKinsey, mechanism, MEDCAC, medication, Memorandum, mentioned, methotrexate, Michigan, mid, misconduct, mission, mobilizing, modify, monitored, month, monthly, morbidity, mortality, myeloablative, myeloid, myocardial, narrow, naturally, NCA, NCD, NDA, necessity, negotiate, Neukine, Neurotrophic, neutrophil, Nevada, NICE, NKF, nonconvertible, NSCLC, Nufil, numeric, Obama, observational, ODAC, odanacatib, opening, organizational, organized, OTC, outlined, overage, overfill, oversee, overseeing, oxaliplatin, oxygen, package, packaged, panel, parathyroid, parathyroidectomy, Parkinson, PBPC, peginesatide, peripheral, permanent, permanently, Petitioner, pharmacodynamic, phosphate, PHS, pilot, platelet, pled, PMC, PMR, polyarticular, polyethylene, Portability, postmarketing, poverty, PPACA, PPO, predate, pregnant, premium, progenitor, proposal, propose, purpura, Pvt, QIP, qui, RA, randomized, ratio, reaction, real, reallocate, reassigned, recognizing, recommended, recommending, recoupment, refer, reforming, regulate, regulator, reject, relator, religrast, relying, repatriation, representation, represented, Reproductive, repurchasing, requested, requesting, resale, reserve, resolve, responding, restate, retaliated, retired, retroactively, retrospectively, revision, rheumatoid, rheumatologic, Rigel, robust, scrutinized, seal, secondarily, separation, serve, shifting, showed, Sicor, signaling, significance, skin, Specialty, spleen, splenectomized, sponsored, standalone, statute, statutorily, stem, step, stimulate, stimulating, stringent, stroke, stub, studying, subpoena, substance, suggest, suggested, SureClick, sustainable, sustaining, symptomatic, syringe, tam, team, Tennessee, testimony, theoretical, therefrom, threshold, thrombocytopenia, thrombocytopenic, thrombopoietin, TNF, tofacitinib, Tom, toxicological, TPO, tracking, trademark, traditionally, transfusion, transplantation, transport, true, unamortized, underage, undergone, undertaken, underway, unidentified, unregistered, unsealed, user, valid, vascular, verify, VHC, violate, Virginia, voted, Warrant, Waterhouse, Watson, Westmoreland, white, wide, widely, writing, wrongful, wrongfully, wrote, Zindrick, zoledronic



Dated:	February 24, 2014	/s/ Robert A. Bradway
		Robert A. Bradway
		Chairman of the Board, Chief Executive Officer and President



Dated:	February 24, 2014	/s/ MICHAEL A. KELLY
		Michael A. Kelly
		Acting Chief Financial Officer


(i)	the accompanying Annual Report on Form 10-K of the Company for the period ended December 31, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and


(ii)	information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


(i)	the accompanying Annual Report on Form 10-K of the Company for the period ended December 31, 2013 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and


(ii)	information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Amgen (AMGN) 10-K2013 FY Annual report

Content analysis